Bidirectional pharmacokinetic drug interactions between olaparib and metformin
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bidirectional pharmacokinetic drug interactions between olaparib and metformin
Authors
Keywords
-
Journal
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-10-10
DOI
10.1007/s00280-023-04591-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Olaparib in an ovarian cancer patient with end-stage renal disease and hemodialysis
- (2023) Joanna Baum et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- An effective AKT inhibitor-PARP inhibitor combination therapy for recurrent ovarian cancer
- (2022) Jing Xu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Metformin Can Enhance the Inhibitory Effect of Olaparib in Bladder Cancer Cells
- (2022) Bao-Jin Chi et al. DISEASE MARKERS
- Co-delivery of sorafenib and metformin from amphiphilic polypeptide-based micelles for colon cancer treatment
- (2022) Xiaohui Zhang et al. Frontiers in Medicine
- Impact of Sotorasib on the Pharmacokinetics and Pharmacodynamics of Metformin, a MATE1/2K Substrate, in Healthy Subjects
- (2022) Irene Vuu et al. CLINICAL PHARMACOKINETICS
- Pharmacokinetics of metformin in collagen-induced arthritis rats
- (2021) Minghao Chen et al. BIOCHEMICAL PHARMACOLOGY
- Metformin Affects Olaparib Sensitivity through Induction of Apoptosis in Epithelial Ovarian Cancer Cell Lines
- (2021) Patrycja Gralewska et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Investigation on factors associated with ovarian cancer: an umbrella review of systematic review and meta-analyses
- (2021) Kiarash Tanha et al. Journal of Ovarian Research
- Gender‐dependent pharmacokinetics of olaparib in rats determined by ultra‐high performance liquid chromatography/electrospray ionization tandem mass spectrometry
- (2020) Guosheng Su et al. BIOMEDICAL CHROMATOGRAPHY
- Mechanisms of action of metformin in type 2 diabetes: Effects on mitochondria and leukocyte-endothelium interactions
- (2020) Nadezda Apostolova et al. Redox Biology
- Pharmacokinetic Interaction between Sorafenib and Atorvastatin, and Sorafenib and Metformin in Rats
- (2020) Agnieszka Karbownik et al. Pharmaceutics
- An olaparib window-of-opportunity trial in patients with early-stage endometrial carcinoma: POLEN study
- (2020) Ignacio Romero et al. GYNECOLOGIC ONCOLOGY
- FDA Approval Summary: Olaparib Monotherapy or in Combination with Bevacizumab for the Maintenance Treatment of Patients with Advanced Ovarian Cancer
- (2020) Shaily Arora et al. ONCOLOGIST
- Biguanides in combination with olaparib limits tumorigenesis of drug‐resistant ovarian cancer cells through inhibition of Snail
- (2019) Qiong Wang et al. Cancer Medicine
- Physiologically Based Pharmacokinetic Modeling for Olaparib Dosing Recommendations: Bridging Formulations, Drug Interactions, and Patient Populations
- (2018) Venkatesh Pilla Reddy et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Development and validation of an analytical method for regorafenib and its metabolites in mouse plasma
- (2018) Qiang Fu et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Metformin and the gastrointestinal tract
- (2016) Laura J. McCreight et al. DIABETOLOGIA
- Preclinical evaluation of olaparib and metformin combination in BRCA1 wildtype ovarian cancer
- (2016) M. Hijaz et al. GYNECOLOGIC ONCOLOGY
- In vitro assessment of the roles of drug transporters in the disposition and drug–drug interaction potential of olaparib
- (2016) Alex McCormick et al. XENOBIOTICA
- Determination of Metformin in Human Plasma and Urine by High-Performance Liquid Chromatography Using Small Sample Volume and Conventional Octadecyl Silane Column
- (2016) Dion Brocks et al. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- A Comprehensive Review of Drug–Drug Interactions with Metformin
- (2015) Tore Bjerregaard Stage et al. CLINICAL PHARMACOKINETICS
- Pharmacokinetic Evaluations of the Co-Administrations of Vandetanib and Metformin, Digoxin, Midazolam, Omeprazole or Ranitidine
- (2014) Susanne Johansson et al. CLINICAL PHARMACOKINETICS
- Association of Organic Cation Transporter 1 With Intolerance to Metformin in Type 2 Diabetes: A GoDARTS Study
- (2014) Tanja Dujic et al. DIABETES
- The prognostic value of metformin for cancer patients with concurrent diabetes: a systematic review and meta-analysis
- (2014) Z.-J. Zhang et al. DIABETES OBESITY & METABOLISM
- Association of metformin use with cancer incidence and mortality: A meta-analysis
- (2013) Pengpeng Zhang et al. Cancer Epidemiology
- Diabetes Mellitus and Ovarian Cancer Risk
- (2013) Jung-Yun Lee et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Metformin pathways
- (2012) Li Gong et al. Pharmacogenetics and Genomics
- Interactions of Tyrosine Kinase Inhibitors with Organic Cation Transporters and Multidrug and Toxic Compound Extrusion Proteins
- (2011) T. Minematsu et al. MOLECULAR CANCER THERAPEUTICS
- New Users of Metformin Are at Low Risk of Incident Cancer: A cohort study among people with type 2 diabetes
- (2009) G. Libby et al. DIABETES CARE
- Organic Cation Transporters and their Pharmacokinetic and Pharmacodynamic Consequences
- (2008) Min-Koo Choi et al. Drug Metabolism and Pharmacokinetics
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started